EXEL Competitors & Alternatives
Compare Exelixis Inc with similar stocks in the same industry
Biotechnology
EXEL
Main Stock$64.81
Tradestie Score
29
Market Cap
$11.09B
P/E Ratio
20.4
Revenue Growth
0.1%
Analyst Upside
-14.3%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$44.07
|
$19.56B | 31.2 | 41 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.02
|
$16.93B | 14.5 | 69 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$63.63
|
$15.70B | 33.1 | 49 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.45
|
$15.22B | - | 52 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$142.08
|
$13.59B | 20.8 | 56 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$243.29
|
$12.36B | 18.3 | 51 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.56
|
$10.76B | - | 57 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$197.27
|
$10.74B | - | 41 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$55.92
|
$10.53B | 149.2 | 73 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$42.87
|
$10.49B | - | 61 | Compare |
More EXEL Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry